Market revenue in 2023 | USD 2,303.5 million |
Market revenue in 2030 | USD 3,888.3 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 63.38% in 2023. Horizon Databook has segmented the Asia Pacific veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The veterinary API manufacturing market in Asia Pacific is expected to grow at a lucrative rate over the forecast period. The market is driven by high investments in R&D by global players and consistent efforts to commercialize veterinary pharmaceuticals at relatively low prices.
In addition, the need to curb the high prevalence of zoonotic disease and manage disease outbreaks, such as swine influenza and Ebola, is expected to propel market growth over the forthcoming decade.Growth in the region can also be attributed to a significantly high cattle population.
According to the report published by the U.S. Department of Agriculture (USDA), in 2023, China and India constitute over 43% of the global cattle population. Furthermore, rising disposable income increases the chances of adopting companion animals, creating future growth opportunities.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account